Overview

Drug-Drug Interaction (DDI) Study of Leramistat in Healthy Adult Subjects

Status:
RECRUITING
Trial end date:
2024-09-30
Target enrollment:
Participant gender:
Summary
A DDI study consisting of 4 parts conducted as an open label, fixed sequence study in healthy adult subjects.
Phase:
PHASE1
Details
Lead Sponsor:
Modern Biosciences Ltd
Treatments:
Itraconazole
Phenytoin
Simvastatin
upadacitinib